[lu-177]-pnt2002,pnt2002,abiraterone,enzalutamide
janssen,point biopharma,pfizer,point biopharma,astellas
['pnt2002', 'pnt2002 ', 'splash', 'prostate']
efficacy and safety of 177lu-pnt2002 psma therapy in metastatic castration-resistant #prostatecancer: initial results from the #splash trial. presented by aaron hansen bsc, mbbs, fracp . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology